Skip to content
A

Anil Wanjari

Publications (8)

Recent Advances in Insulin Delivery Devices and Modes of Insulin Therapy

Ishita Rai, Anil Wanjari & Sourya Acharya · Journal of Pharmaceutical Research International · 2021

The discovery of insulin was 100 years old till 2021. Insulin, the first diabetic medication, is now the safest and most effective glucose-lowering medication available. Despite its efficacy, the most significant challenge with insulin has been the prevalence of hypoglycemia, whi...

Open access Research Article 10.9734/jpri/2021/v33i57B34067

Labour Induction Methods: An Overview

Sanjivani Wanjari & Anil Wanjari · Journal of Pharmaceutical Research International · 2021

Overall the rate of induced labours has increased and almost 25% of women undergo labour induction worldwide. Cervical ripening and cervical preparedness is necessary before labour can be induced. The status of the cervix is traditionally assessed with help of Bishop’s score. Lab...

Open access Research Article 10.9734/jpri/2021/v33i37A31987

Estimating the Correlation of Ankle Brachial Index with Vascular Risk Factors in Pre-diabetics

Neha Phate, Sunil Kumar, Sourya Acharya, Anil Wanjari, Sachin Agrawal & Shilpa Gaidhane · Journal of Pharmaceutical Research International · 2021

Background: Prediabetes is characterized by a long duration of insulin resistance and increased fasting plasma glucose. Among the various risk factors for cardiovascular atherosclerosis and prediabetes, insulin resistance is one of them. Glycemia has been recognized to affect mic...

Open access Research Article 10.9734/jpri/2021/v33i63B35285

Effect of Diet on Non-Alcoholic Fatty Liver Disease

Aditi Mishra, Avinash Padale, Tamana Manwani, Anil Wanjari & Sourya Acharya · Journal of Pharmaceutical Research International · 2021

Non - alcoholic fatty liver disease (NAFLD) is instantaneously progressing to the commonest and dangerous liver disease, with a diverse variety of fat-liver diseases that can progress to extreme hepatic disorders and cirrhosis. Inflammatory processes influence aetiologia of non-a...

Open access Research Article 10.9734/jpri/2021/v33i63A35903

Obesity Related Cardiovascular Diseases and Diagnosis

Avinash Padale, Aditi Mishra, Tamana Manwani, Anil Wanjari & Sourya Acharya · Journal of Pharmaceutical Research International · 2021

Obesity is defined as a condition in which the amount of adipose tissue in the body is excessive and there has been many researches proving a strong correlation between cardiovascular diseases in obese individuals. The elevated incidence of many identified risk factors including...

Open access Research Article 10.9734/jpri/2021/v33i60B34813

Unintended Inhalational Organophosphate Poisoning Presenting as Angioedema: A Rare Case Report

Sanyukta Hepat, Abhijit Wadekar, Gaurav Jagtap, Vijay Kota & Anil Wanjari · Journal of Pharmaceutical Research International · 2021

Organophosphorus compounds are chemical agents in widespread use throughout the world, mainly in agriculture. In developing countries organophosphorus (OP) poisoning is a commonly encountered problem. Here we present a rare case of OP poisoning with angioedema as the presenting f...

Open access Research Article 10.9734/jpri/2021/v33i52A33574

Estimation of Serum Sodium, Potassium and Calcium Levels as Prognostic Markers in Cirrhosis of Liver: A Study Protocol

Twinkle Pawar, Rajesh Sarode, Vijendra Kirnake, Sunil Kumar, Sourya Acharya, Shilpa Bawankule, Anil Wanjari & Sachin Agrawal · Journal of Pharmaceutical Research International · 2021

Background: Cirrhosis of the liver is final stage of chronic liver disease [1], which can lead to complications associated with portal hypertension and liver failure. In a much remunerated state, the cirrhotic patient maintains close association to traditional solution and acid–b...

Open access Research Article 10.9734/jpri/2021/v33i64A35314